Insider Cluster (2 insiders) ·Filed Jul 1, 2026

RVMD

Revolution Medicines, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed3mo ago
Insider cluster: 2 insiders, $817K total
Actionable Insight • Neutral

Insider sales are immaterial relative to market cap and likely driven by routine portfolio diversification or tax planning. The CFO's $762K sale is a single transaction at a $39.9B market cap — no bearish signal. Monitor for any upcoming data readouts or regulatory catalysts that could drive the stock, but this cluster has no actionable trading edge.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
RVMD ▲ +6.59% at T+60d
NEUTRAL call ✓ call won +6.59% · α vs SPY +3.63% · entry $187.51 → $199.86
Entry anchored
Jun 30, 03:59 PM ET
via exchange tick
T+1d
+0.92%
call +0.92% · α +1.05%
$189.24
settled 3mo ago
T+5d
+1.57%
call +1.57% · α +1.31%
$190.46
settled 3mo ago
T+20d
-3.51%
call -3.51% · α -1.33%
$180.92
settled 2mo ago
T+60d
+6.59%
call +6.59% · α +3.63%
$199.86
settled 8d ago

Price Chart

Loading chart...

Executive Summary

Two insiders at Revolution Medicines sold a total of $817K in stock over a 7-day window. CFO Jack Anders sold $762K (4.6K shares at $167.34) and Director Patel Sushil sold $55K (300 shares at $183.17) after exercising options. The total sales represent ~0.002% of the $39.9B market cap — a trivial amount with no material signal.

Key Financial Metrics

Direction
selling
Total Value
$817.0K
Insiders
2

Key Facts

  • CFO Jack Anders sold $762K worth of RVMD stock on 2026-06-24 at $167.34/share
  • Director Patel Sushil sold $55K worth of RVMD stock on 2026-06-29 at $183.17/share
  • Total insider sales of $817K represent ~0.002% of RVMD's $39.9B market cap
  • Patel Sushil also exercised options for 2,955 shares at $37.54/share on 2026-06-29
  • No open-market insider purchases in the cluster window

Financial Impact

Total insider sales of $817K represent ~0.002% of RVMD's $39.9B market cap — a trivial amount

insider ownership

Risk Factors

  • Insider sales could accelerate if stock continues to appreciate
  • No open-market purchases to signal insider conviction

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
96% bullish (27 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RVMD-1782976983692
26 reports for RVMD
Performance horizon
100% Hit rate 12 of 12 directional calls best @ T+60▲ +31.56%Apr 21, 2026
Filters
Rows
Reports for RVMD — sortable, filterable
TypeNow
Sep 15, 2026
16d ago
144
NEUTRAL ★ 2/10
$195.92 $190.74▼ −2.64%▼ −5.21%$206.64 (+5.47%)
Sep 15, 2026
16d ago
144
NEUTRAL ★ 4/10
$195.92 $190.74▼ −2.64%▼ −5.21%$206.64 (+5.47%)
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$204.86 $190.95▼ −6.79%▼ −7.61%$206.64 (+0.87%)
Sep 14, 2026
17d ago
Insider Cluster
NEUTRAL ★ 3/10
$204.86 $192.86▼ −5.86%▼ −7.98%$206.64 (+0.87%)
Aug 26, 2026
5w ago
8-K
BULLISH ★ 8/10
$215.44 $209.23▼ −2.88%▼ −2.76%$206.64 (−4.08%)
Aug 26, 2026
5w ago
Press Release
BULLISH ★ 8/10
$215.44 $209.23▼ −2.88%▼ −2.76%$206.64 (−4.08%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$211.38 $209.87▼ −0.71%▼ −0.18%$206.64 (−2.24%)
Jul 2, 2026
13w ago
Press Release
BULLISH ★ 7/10
$189.24 $191.13▲ +1.00%▲ +0.07%$206.64 (+9.19%)
Jul 1, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$187.51 $190.46▲ +1.57%▲ +1.31%$206.64 (+10.20%)
Jun 22, 2026
14w ago
8-K
NEUTRAL ★ 2/10
$165.81 $192.62▲ +16.17%▲ +16.62%$206.64 (+24.62%)
Showing 10 of 26

US Market Status

Market Closed — Opens Mon (64h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 2, 2026